QSC Tirzepatide is a high-quality peptide compound with triple agonist activity targeting glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). This pharmaceutical grade material is supplied as a white lyophilized powder for research purposes only.
The QSC Tirzepatide formulation has demonstrated significant potential in clinical studies for weight management and glucose control applications. As a research chemical, it shows promise for investigating metabolic disorders including obesity and type 2 diabetes mellitus (T2DM).
Our QSC Tirzepatide is manufactured under strict quality control standards to ensure 99% purity. The product is available in various concentrations to meet different research requirements. Proper storage at frozen conditions (-20°C or below) is essential to maintain stability.
This peptide product is intended for laboratory research use only and not for human consumption. Researchers should follow proper handling procedures and refer to technical documentation for specific storage and preparation guidelines.